The biological cost of antibiotic resistance

Current Opinion in Microbiology

Volumn 2, Issue 5, 1999, Pages 489-493

  Andersson, Dan I ^a   Levin, Bruce R ^b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FUSIDIC ACID; ISONIAZID; NALIDIXIC ACID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CHROMOSOME MUTATION; GENE ACTIVITY; GENE LOCUS; GENE MUTATION; GENETIC RESISTANCE; NONHUMAN; REVIEW;

BACTERIA (MICROORGANISMS);

EID: 0032870940     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)00005-3     Document Type: Review

References (37)

1. Bloom BR, Murray CJL Tuberculosis - commentary on a reemergent killer. Science. 257:1992;1055-1064.
2. Cohen ML Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 257:1992;1050-1055.
3. Levy SB The Antibiotic Paradox: How Miracle Drugs are Destroying the Miracle. 1992;Plenium Press, New York.
4. McCormick JB Epidemiology of emerging/re-emerging antimicrobial-resistant pathogens. Curr Opin Microbiol. 1:1998;125-129.
5. •].
6. •] illustrate two different approaches to the development of mathematical models of the population genetics and epidemiology of antibiotic resistance. These two papers are part of a growing literature on this subject by population and evolutionary biologists. These theoretical studies provide the necessarily quantitative information needed to unambiguously identify and evaluate the role of the different factors contributing to the ascent and maintenance of drug resistance, and to interpret the results of epidemiological studies of the relationship between drug use and drug resistance.
7. Björkman J, Hughes D, Andersson DI Virulence of antibiotic resistant Salmonella typhimuirium. Proc Natl Acad Sci USA. 95:1998;3949-3953. This investigation illustrates the importance of estimating the fitness costs of antibiotic resistance and effects of evolution on those cost in vivo as well as in vitro. Different results can be obtained with similar experiments performed in experimental mice and in laboratory media.
8. Björkman J, Samuelsson P, Andersson DI, Hughes D Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol. 31:1999;53-58. This article explores in detail the mechanism by which genetic compensation is conferred in streptomycin resistant bacteria.
9. Levin BR: Conditions for the existence of R-plasmids in bacterial populations. In Fourth International Symposium on Antibiotic Resistance. Edited by S Mitsuhashi, L Rosival, L, V Krcmery. Aviceum Prague; Springer-Verlag, Beslin: 1980:197-202.
10. Bouma JE, Lenski RE Evolution of a bacteria/plasmid association. Nature. 335:1988;351-352.
11. Modi RI, Adams J Coevolution in bacteria-plasmid populations. Evolution. 45:1991;656-667.
12. Schrag S, Perrot V, Levin BR Adaptation to the fitness cost of antibiotic resistance in Escherichia coli. Proc R Soc London. 264:1997;1287-1291.
13. Dykhuizen DE, Hartl DL Selection in chemostats. Microbiol Rev. 47:1983;150-168.
14. Lenski RE Quantifying fitness and gene stability in microorganisms. Biotechnology. 15:1991;173-192.
15. Lenski RE, Simpson SC, Nguyen TT Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J Bacteriol. 176:1994;3140-3147.
16. Modi RI, Wilke CM, Rosenzweig RF, Adams J Plasmid macro-evolution: selection of deletions during adaptation in a nutrient-limited environment. Genetica. 4:1991;195-202.
17. Bryan LE General mechanisms of resistance to antibiotics. J Antimicrob Chemother. 22(suppl A):1988;1-15.
18. Neu HC Overview of mechanisms of bacterial resistance. Diagn Microbiol Infect Dis. 12(suppl 4):1989;109-116.
19. Dever LA, Dermody TS Mechanisms of bacterial resistance to antibiotics. Arch Intern Med. 151:1991;886-895.
20. Musser J Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev. 8:1995;496-514.
21. Maiden MC Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria. Clin Infect Dis. 27(suppl 1):1998;12-20.
22. Marshall NJ, Piddock LJ Antibacterial efflux systems. Microbiologia. 13:1997;285-300.
23. Davies J Inactivation of antibiotics and the dissemination of resistance genes. Science. 264:1994;375-382.
24. Helling RB, Kinney T, Adams J The maintenance of plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol. 123:1981;129-141.
25. Lee SW, Edlin G Expression of tetracycline resistance in pBR322 derivatives reduces the reproductive fitness of plasmid-containing Escherichia coli. Gene. 39:1985;173-180.
26. McDermott PJ, Gowland P, Gowland PC Adaptation of Escherichia coli growth rates to the presence of pBR322. Lett Appl Microbiol. 17:1993;139-143.
27. Smith MA, Bidochka MJ Bacterial fitness and plasmid loss: the importance of culture conditions and plasmid size. Can J Microbiol. 44:1998;351-355.
28. Levin BR, Perrot V, Walker NM Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics. 1999;. in press, This jointly theoretical and experimental study considers why mutants that compensate for the costs of resistance rather than drug sensitive revertants evolve in experimental studies of the adaptation to the costs of antibiotic resistance.
29. Borman AM, Paulous S, Clavel F Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. J Gen Virol. 77:1996;419-426.
30. Gerdes K, Rasmussen PB, Molin S. Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. Proc Natl Acad Sci USA. 83:1986;3116-3120.
31. Böttger EC, Springer B, Pletschette M, Sander P Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nature Med. 4:1998;1343-1344. This study shows that the resistance mutations found in clinical isolates of Mycobacterium tuberculosis were exclusively those that conferred no costs in laboratory experiments.
32. Schrag S, Perrot V Reducing antibiotic resistance. Nature. 381:1996;120-121.
33. Sherman DR, Mdluli K, Hickey MJ, Arain TM, Morris SL, Barry CE III, Stover KC Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science. 272:1996;1641-1643.
34. Johansson U, Evarsson A, Liljas A, Hughes D The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants. J Mol Biol. 258:1996;420-432.
35. Wilson TM, de Lisle GW, Collins DM Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol. 15:1995;1009-1015.
36. Heym B, Stavropoulus E, Honore N, Domenech P, Saint-Joanis B, Wilson T, Collins D, Colston MJ, Cole S Effects of overexpression of the alkyl hydroxyperoxidase reductase AphC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Inf Imm. 65:1997;1395-1401.
37. Zhongming L, Kelley C, Collins F, Rouse D, Morris S Expression of katG in Mycobacterium tuberculosis is associated with it growth and persistence in mice and guinea pigs. J Infect Dis. 177:1997;1030-1035.